Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients

Authors Nagai K, Makita H, Suzuki M, Shimizu K, Konno S, Ito YM, Nishimura M

Received 15 November 2014

Accepted for publication 23 January 2015

Published 10 April 2015 Volume 2015:10(1) Pages 745—757

DOI https://doi.org/10.2147/COPD.S77586

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Richard Russell

Katsura Nagai,1 Hironi Makita,1 Masaru Suzuki,1 Kaoruko Shimizu,1 Satoshi Konno,1 Yoichi M Ito,2 Masaharu Nishimura1

On behalf of the Hokkaido COPD Cohort Study Investigators

1First Department of Medicine, Hokkaido University School of Medicine, 2Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Background: The aim of the study was to examine the longitudinal change in quality of life components of patients with chronic obstructive pulmonary disease (COPD).
Methods: In the Hokkaido COPD Cohort Study, 261 subjects were appropriately treated and followed over 5 years with a 74% follow-up rate at the end. The longitudinal changes in St George’s Respiratory Questionnaire (SGRQ) scores were annually evaluated with forced expiratory volume in 1 second (FEV1). The subjects were classified into the rapid decliners, slow decliners, and sustainers based on ∆FEV1/year.
Results: The activity component of SGRQ generally deteriorated over time, and its annual decline was the greatest in the rapid decliners (<25th percentile). In contrast, the symptom component improved significantly year by year in the sustainers (>75 percentile), and it did not deteriorate even in the rapid decliners. Of the baseline data, predictors for worsening of the activity component were older age and lower body mass index. Larger reversibility was related to symptom component improvement. Of the follow-up data, ∆FEV1/year was the best predictor for worsening of the components of SGRQ. Continuous smoking was another factor for worsening of the activity component. For the symptom component, a history of exacerbation by admission definition was the determinant of its deterioration, whereas use of beta agonists was related to improvement.
Conclusion: The longitudinal changes of quality of life and their determinants are markedly different and independent between its components. The activity component of SGRQ generally deteriorated over years, while the symptom component rather improved in some patients with COPD under appropriate treatment.

Keywords: annual change, forced expiratory volume in 1 second, SGRQ, smoking, exacerbation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes

Zhang JQ, Zhang JQ, Liu H, Zhao ZH, Fang LZ, Liu L, Fu WP, Shu JK, Feng JG, Dai LM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:917-923

Published Date: 13 May 2015

Caregivers’ burden in patients with COPD

Miravitlles M, Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:347-356

Published Date: 12 February 2015

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:239-259

Published Date: 5 February 2015

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer

Wu SK, Chiang CF, Hsu YH, Lin TH, Liou HC, Fu WM, Lin WL

International Journal of Nanomedicine 2014, 9:4485-4494

Published Date: 19 September 2014

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:975-981

Published Date: 15 September 2014

Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles

Omwoyo WN, Ogutu B, Oloo F, Swai H, Kalombo L, Melariri P, Mahanga GM, Gathirwa JW

International Journal of Nanomedicine 2014, 9:3865-3874

Published Date: 11 August 2014

Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction

Carole Nadin

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005